Cytrellis Biosystems is launching the next generation of its ellacor system with Micro-Coring technology.
The ellacor system with Micro-Coring technology is the first and only minimally invasive, in-office procedure to remove sagging skin, treat wrinkles, and rejuvenate skin. Cleared by the U.S. Food and Drug Administration (FDA) in 2021, this system works on a micro-scale to target moderate and severe wrinkles in the mid and lower face. Micro-Coring is a proprietary technology that removes skin surface area and stimulates the body’s natural healing process. It uses hollow needles to remove micro-cores of dermal and epidermal tissue without surgery, thermal energy or evidence of scarring.
The updated ellacor (ellacor 2.0) offers user-friendly technology and new protocols for enhanced patient and provider satisfaction, including:
- A new needle design and software enhancements. The redesigned needle boosts coring capabilities and ergonomics. Additionally, the software has been optimized. The velocity is now twice as fast, reducing treatment time and minimizing trauma to the dermis. The suction is 30% stronger, providing better visibility of the flange footprint and improving the reliability of core removal during the procedure. The needle redesign and software enhancements result in more precise core excision and improved wound closure and recovery.
- Revised and simplified treatment protocols. These new protocols enhance patient recovery and the consistency of the procedure’s results. The updated protocols were tested with 80 physicians and more than 100 patients, who reported achieving more consistent results with fewer manual adjustments.
The enhanced clarity of procedural instructions and updates improved patient outcomes. Patients indicated they felt 50% more comfortable during the procedure, and self-reported downtime was reduced to 3.4 days, the Company reports. Clinicians also reported better overall experience and reduced procedure time.
“When new technology enters the market, it is common to release updated versions to refine best practices and optimize performance. These updates often incorporate feedback from early users who uncover enhancement opportunities not seen during initial development,” says Dr. Denise Dajles, President and CEO of Cytrellis, in a news release. “ellacor 2.0 represents the extensive work we did to listen to users about their experiences. Their feedback was instrumental and led to standardizing techniques and improving user experience.”
